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Hyperacute Rejection of the Kidney in Patients With a 
Negative Crossmatch 
B. Banner, L. Makowka, J. Demetris, A. Tzakis, M. Griffin, and T.E. Starzl 
HYPERACUTE rejection (HAR) of the kidney was first recognized 20 years 
ago in cases of donor-recipient incompatibility 
for the major blood group and tissue antigen 
systems. I•3 Recently, three patients at the Uni-
versity of Pittsburgh developed immediate 
graft dysfunction after receiving a kidney 
from an ABO-compatible cadaveric donor 
with a negative warm lymphocytotoxic cross-
match. None of the patients had prior trans-
plants or transfusion therapy, and the 
ischemia times were comparable. One 
patients had a high panel reactive antibody 
(PRA) (100% remote, 76% at transplant). 
The immunopathologic and histopathologic 
features of these cases were compared with 
those of a control group without HAR. Our 
findings suggest that the cascade involved in 
HAR may be triggered by mechanisms other 
than those classically described. 
MATERIALS AND METHODS 
Tissue Processing 
The tissue spcc:imens from the three kidneys with HAR 
and a control group including seven unused donor kid-
neys. two baseline biopsy specimens after reperfusion. one 
preanastomosis biopsy sample. and one allograft resected 
at three days for renal vein thrombosis were processed 
routinely for light microscopy. 
For immunofluorescence (IF). snap-frozen sections 
were cut at 4 I'JJl and reacted with fluorescein isothiocya-
nate-labeled primary antisera to IgG (1:20). IgM (1:15). 
19A (1:15). Clq (1:20). C3 (1:20). C4 (1:8). and fibrino-
gen (I :30) from Calbiochem-Behring Corp, Wolla, CA; 
az-macrogiobulin (1:20) and transferrin (1:20) from Cap-
pel Laboratories, WestChester. PA: properdin (1:5) from 
Atlantic Antibodies through Rupp and Bowman; and Leu 
4 (1:60) and Leu 14 (1:25) from Becton Dickinson. 
Mountain View. CA. 
Immunoperoxidase (IP) staining was performed on the 
paraffin blocks by using a Vectastain ABC kit (Vector 
Laboratories Burlingame. CAl. with primary antibodies 
to IgG (1:1.000) and IgM (1:1.000) from Dako (Santa 
Barbara. CAl. and Clq (1:40) from Behring Diagnostics 
(La Jolla. CAl. The chromogen was 3'3-diaminobenzi-
dine (Polysciences. Inc. Warrington. PAl. 
RESULTS 
Case J 
A 61-year-old black male, blood type A, 
with long-standing ulcerative colitis and scle-
rosing cholangitis was referred for liver trans-
plantation because of increasing jaundice. 
During the workup he was found to be in renal 
failure attributed to drug-related interstitial 
nephritis and liver failure. He underwent 
cadaveric liver transplantation, which was fol-
lowed immediately by kidney transplantation. 
The donor was a 28-year-old white male. 
blood type A, who died of subarachnoid hem-
orrhage. The PRA was 0%. The ischemia time 
was 24 hours. The lymphocytotoxic cross-
match was doubtfully positive just before sur-
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gery and negative just after. The kidney 
became cyanotic immediately afte; unclamp-
ing. Papaverine and prostaglandins were 
administered. The kidney was removed after 
eight hours. RBC-platelet thrombi with rare 
polymorphonuclear leukocytes (PMNs) were 
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present in the vascular poles of less than 10% 
of the glomeruli (Fig lA). There was positive 
immunostaining for IgM and Clq in vessel 
walls (Figs IB and C); IgG was negative. 
On the following day the level of liver 
enzymes rose markedly. The patient received 
Fig 1. Ca.. 1. reuctlld allograft kidney end liver. (A) Glomerulus with thrombosis at the vaacul8r pole 
(hematoxylin-eoain [H.E): original magnification x 200 for all penels except penel 0). (B) PositivalP staining for IgM 
in an anarlole. Staining in glomerular capillary lurni". is nonspecific. IC) Positive IP staining for C1 Q In tha _1Ia of 
tha interlobular anery. (0) Allograft livar showing large araas of infarction. (EI PositivalP staining for IgM In anery 
walla. IF) PositivalP staining for C1 Q in the same anery. 
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a second liver transplant on the fourth day, 
but he did poorly and died, without autopsy, 
on the sixth day. The resected allograft liver 
showed geographic areas of infarction not 
limited to the subcapsular regions (Fig ID). 
IgM and C I q were present in artery walls 
(Figs I E and F). Examination of the native 
liver revealed a bile duct carcinoma in addi-
tion to pericholangitis. 
Case 2 
A 49-year-old white female, blood type A. 
',ith chronic glomerulonephritis and a history 
of Grave's disease received a cadaveric kidney 
from a 51-year-old white female, blood type 
A, who died of a cerebrovascular accident. 
The warm lymphocytotoxic crossmatch was 
negative. The patient had a high PRA (99% 
remote and 76% at the time of kidney trans-
plantation). The ischemia time was 20 hours. 
After unclamping, the transplanted kidney 
became cyanotic. Papaverine and prostaglan-
dins were administered, but the kidney had to 
be removed after five hours. Microscopically, 
there were nuclear fragments and inflamma-
tory cells in 40% of the glomeruli (Fig 2A). 
Only rare thrombi were present in glomerular 
capillaries. There was only trace-positive IF 
immunostaining for IgM in the mesangium 
and C Iq, C3, and properdin at the vascular 
pole of some glomeruli. Leu 4 (T cell)-positive 
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cells~ere present in 30% of the glomeruli (Fig 
2B). 
Case 3 
A 60-year-old white male, blood group 0, 
with end-stage polycystic renal disease 
received a kidney from a 30-year-old white 
male, blood group 0, who died in a motor 
vehicle accident. The PRA was 2%, and the 
warm lymphocytotoxic crossmatch was nega-
tive. The ischemia time was 32 hours. It was 
learned that gram-negative rods had been 
cultured from the donor's trachea and signifi-
cant Pseudomonas organisms from his urine. 
The kidney became soft and dusky 15 to 20 
minutes after unclamping, and the patient 
became hypotensive. Papaverine was adminis-
tered without effect. The kidney was removed 
after five hours. The mate kidney was not used 
for transplantation, and so both kidneys were 
available for pathological examination. 
The resected allograft contained RBC-
platelet thrombi with neutrophils in 66% of 
the glomeruli, about 10% of which were 
necrotic as well (Fig 3A). The tubules showed 
acute tubular necrosis (A TN), and one small 
arterial thrombus was present. The unused 
mate kidney was normal by light microscopy 
(Fig 4A). By IF staining, there was 2+ IgM 
and trace C3 and properdin in the mesangium 
of the allograft (Figs 3B C, and D). The mate 
Fig 2. Ca.e 2. resected allograft kidney. (A) PMNa and karyorrhectic nuclear debris in a glomerulua (HllaE: 
original magnification x 200 for both panels). (B) PositivelP staining for leu 41T cells' at arrows. 
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Fig 3. Case 3. resected allograft kidney. IA) Glomerulus with thromboaia. congestion. and PMNa IH80:E: original 
magnification x200 in all panela). lB. C. and D) Positive IF immunoataining forlgM. C3. and properdin. 
reapectively. 
kidney contained C3 and properdin in similar 
distribution (Figs 4B and C). 
Control Cases 
Light microscopic and· immunostaining 
results of the non·HAR kidneys are in Table I 
along with those of the three cases described. 
Four cases with extensive glomerular throm-
bosis due to disseminated intravascular coag-
ulation (DIC) (three cases) and malignant 
hypertension (one case) exhibited light micro-
scopic findings similar to those in classic 
HAR, ie, glomerular thrombosis and cortical 
necrosis. Immunoglobulins and complement 
were demonstrable in the thrombi but not in 
the walls of the arteries and arterioles. The 
cases with normal histology or simple A TN 
did not exhibit significant immunostaining. 
The patient who developed renal vein throm-
bosis for technical reasons had an ABO-
compatible donor, negative PRA, and nega-
tive crossmatch. The kidney that was removed 
at three days exhibited renal vein thrombosis, 
acute interstitial hemorrhages, and severe 
A TN. The glomeruli were filled with RBes 
and PMNs. IF staining showed only trace 
C I Q in a few artery walls. 
DISCUSSION 
HAR of the kidney was recognized 20 years 
ago in transplants across major blood group 
and tissue antigen systems,I-4 and in some 
patients with negative crossmatches.3 Classic 
pathological changes described include early 
accumulation of PMNs in glomeruli and peri-
tubular capillaries, progressive glomerular 
thrombosis, tubular necrosis, and eventual 
K--~--------~ .. --
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Fig 4. Case 3. unused donor kidney. (AI Glomerulus (H8tE; original magnific.ation x 200 in all panelsl. (8 and CI 
Positive IF immunoataining for C3 and properdin. respectively. 
cortical necrosis. Reaction of host humoral 
antibodies with antigens on donor cells serves 
as one trigger of the clotting mechanism, 
which then proceeds in a nonspecific fash-
ion.2•s 
Antigen systems other than the ABO 
groups that contribute to HAR reactions are 
leukocyte antigens,6 endothelial and monocyte 
antigens/ and B cell antigens.8 It is also 
documented that glomerular thrombosis iden-
tical to HAR may occur secondary to endo-
thelial damage a~ter pulsatile perfusion.9 
However, in such cases no specific deposition 
of immunoglobulins and complement is 
detected.9 Our cases did not fit the established 
pathogenetic concepts. Although all three had 
a classic HAR rejection clinically, the patho-
logical findings vary and suggest that still 
other factors of sufficient magnitude to incite 
a HAR reaction, yet be undetectable in stan-
dard tests, may also be effective triggers of the 
cascade. 
In the first case, the deposition of IgM and 
CIQ in arterial walls in both the kidney and 
liver supports the clinical impression that a 
HAR reaction occurred in both organs, even 
though thrombi were demonstrable only in a 
few glomeruli. The doubtful positive cross-
match converting to normal suggests that 
antibodies were consumed. It is possible that 
the drug therapy altered or reversed the coag-
ulopathy. The trigger for the coagulation cas-
cade is not known. Possibly the patient had 
antibodies to some tissue antigens as the result 
of his autoimmune disorders or his bile duct 
carcinoma. The second patient also had an 
episode of HAR that was typical clinically but 
not histologically. There were no glomerular 
thrombi; instead, there was karyorrhectic 
nuclear de'bris and increased numbers of T 
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Table 1. Pathological Findings in Cases of Hyp,racute Rejection. Unused Donor Kidneys. B.seline Biopsies. 
and Renal Vein Thrombosis 
Caaee Light Microlcopy 106 IgM C1Q C3 ~ 
Hyperacute re jection 
1 Glomeruler thrombosis 0 Art Art NA NA 
Gloms Gloms 
2 Nuclear fragments 0 Mea Art Art Art 
3 Glomeruler thrombosis 
used: 0 Mes Mea Mea Mea 
unused: 0 0 Mes Mes Mas 
Unused donor kidney 
4,GSW DIC 0 Thr Thr NA NA 
5,GSW DIC, 0 Thr Thr Thr Thr 
6, stroke Malignant nephrosclerosIs Thr Thr Thr Thr Thr 
7, sepsis DIC, Thr Thr Thr Thr NA 
8, lac. renal vein Normal 0 0 0 NA NA 
9, SepSIS ATN 0 0 0 NA NA 
10, viremia Normal 0 0 Mas NA NA 
Baseline biopsies 
1 1, postperfusion Normal 0 0 0 NA NA 
1 2, postperiusion Normal 0 0 0 NA NA 
1 3, preanastamosis Normal 0 0 0 NA NA 
Renal vein thrombosis 
14 Hemorrhage 0 0 Art 0 0 
Abbreviations: NA, not applicable; Mes. mesangial; Thr, thrombus; Art, arterial wall; GSW. gunshot wound. 
cells. We found T cells only rarely in glo-
meruli from other cases. The patient's high 
PRA implicates an initial reaction with some 
HLA antigens on endothelial cells despite a 
close HLA match between donor and recip-
ient. The pathological findings suggest a 
mechanism by which T cells either mediate 
cytotoxicity within the glomerulus or are 
recruited very early in the process. The third 
patient had a typical HAR. both clinically and 
histologically. The presence of C3 and pro-
perdin in both used and unused kidneys and 
the history of gram-negative infection in the 
donor suggest that the sequence of events in 
this case started with endotoxin activation of 
complement in the donor. Upon reperfusion. 
this Schwartzman reaction continued in the 
new host. 
Another unusual feature of our cases is that 
IgM and not IgG, as previously reported,J was 
found consistently along with CIQ in the 
tissues. IgM antibodies may appear earlier 
than IgG antibodies and thus be more readily 
detectable in tissue during the first few hours. 
We found deposition of IgM and complement 
in arterial walls only in HAR. Other kidneys 
with widespread thrombosis and necrosis due 
to DIC exhibited either immunoglobulin and 
complement deposition in thrombi, but not in 
arterial walls, or deposition of only comple-
ment in vessel walls. This suggests that 
IgM-C' in vessel walls may be a specific 
indicator of vascular rejection. 
In summary, three patients with ABO-
compatible donors and negative crossmatches 
had clinically typical episodes of hyperacute 
rejection. They demonstrated varied histologi-
cal and immunopathologic findings, which 
suggests that HAR may occur when clinical 
and laboratory predictors are negative and 
that different pathogenetic mechanisms, in-
cluding nonimmunologic ones, may lead to 
activation of the clotting sequence. IgM and 
complement deposition may be a specific 
marker for HAR of the kidney. 
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